VN June 2022

Vetnews | Junie 2022 31 Essential Fatty Acids (EFAs) come from dietary fat. The body has a physiological requirement for two distinct families of EFAs: the omega 6(n-6) and omega 3(n-3) series. All EFA are polyunsaturated. The most significant fatty acid in the n-6 series is linoleic acid (sources include: corn, soybean, sunflower oils, poultry and pork fat). In most animals, gamma- linoleic acid (GLA) and arachidonic acid (AA) can be synthesized from linoleic acid; therefore, there is no dietary requirement if there is enough LA in the diet for GLA and AA. Although the dog can synthesize adequate amounts of these fatty acids during all life stages, the cat is one of the species that does not synthesize sufficient amounts of AA during all life stages, even if linoleic acid is present in the diet. As a result, AA is considered to be conditionally essential for the cat during pregnancy and normal neonatal development. In the n-3 family, alpha-linolenic acid (ALA) is essential in dogs and cats. The conversion of ALA to physiologically necessary long-chain PUFAs such as EPA and DHA is limited, leading to dietary requirements during periods of reproduction and development. During metabolism, the n-6 and n-3 families complete for the same enzymes and metabolic pathways, although their end products differ; therefore, the effects of these fatty acids will be influenced by both their absolute quantities in the diet and their relative levels each other. Linoleic acid & Arachidonic acid Linoleic acid has essential functions in maintaining the epidermal water barrier in the skin. It is incorporated into a fraction of cellular phospholipids in the epidermal keratinocytes called ceramides. The most crucial long- chain polyunsaturated fatty acid produced from linoleic acid is AA, a major cell membrane fatty acid and a precursor of certain types of eicosanoids. Eicosanoids are produced and released from cell membranes in response to physical and chemical trauma and have local effects on the immune and inflammatory response. The four primary types of eicosanoids are prostaglandins, prostacyclins, thromboxanes and leukotrienes. AA, which generally comprises more than 20% of the total fatty acids in cell membrane phospholipids in the skin, is converted to prostaglandins of the two series (prostaglandin E2) and leukotrienes of the four series (leukotriene B4) These eicosanoids are pro-inflammatory and are central mediators of inflammatory and allergic responses. Alpha-Linolenic Acid, EPA & DHA The primary role of ALA is to act as the parent fatty acid for the synthesis of EPA and DHA. There is evidence that ALAmay contribute to a healthy trans epidermal water barrier. It has a sparing effect on linoleic acid as a source of LCPUFAs, which allows the accumulation of linoleic acid in the ceramide fraction of the skin. EPA is incorporated into cell membranes and, like AA, serves as a precursor for the eicosanoids. Important eicosanoids produced from EPA are prostaglandins of the three series (prostaglandin E3) and leukotrienes of the five series (leukotriene B5).These eicosanoids are less potent mediators of inflammation than those produced from AA and can effectively reduce inflammatory and allergic responses when they replace AA; therefore, they form the basis for n-3 fatty acids inmanaging inflammatory disorders. DHA is found in large amounts in the cell membranes of neurological tissues and is one of the most abundant fatty acids found in the retina. It is essential for normal neurological and visual development during foetal and neonatal life. ALA can be converted to DHA in very young animals and is less effective in adults. The amount and type of n-3 and n-6 fatty acids and the ratios of these two classes of fatty acids in the diet must be considered when determining effects on plasma and tissue levels and consequent eicosanoid synthesis. An early study with healthy dogs showed that feeding a diet containing n-6 to omega-three ratios between 5:1 and 10:1 resulted in significantly lower levels of LTB4. It also shows significantly higher levels of the less inflammatory metabolite LTB5 in the skin compared with levels produced when the dogs were fed a diet with ratios of 28:1 or higher. Results of studies have suggested that when a favourable ratio is included in the diet, increasing the source of EPA and DHA while maintaining a constant n-6 to n-3 ratio positively affects plasma fatty acid profiles and, presumably (although not yet reported), the production of less inflammatory eicosanoids. TheNational ResearchCouncil (NRC) recommends a 2.6:1 to26:1 omega-6 to omega-3 ratio. v Essential fatty acids

RkJQdWJsaXNoZXIy OTc5MDU=